Financial Performance - The company's revenue for Q3 2022 reached ¥263,100,556.93, representing a 106.48% increase year-over-year[5] - Net profit attributable to shareholders for Q3 2022 was ¥42,529,092.10, up 12.29% compared to the same period last year[5] - The operating income for the first nine months of 2022 was ¥695,072,683.55, a 106.57% increase from ¥336,478,740.95 in the same period last year[8] - Total operating revenue for the third quarter of 2022 reached CNY 695,072,683.55, a significant increase of 106.7% compared to CNY 336,478,740.95 in the same period last year[17] - The net profit for the third quarter of 2022 was CNY 121,030,482.04, an increase of 10.3% compared to CNY 109,865,346.84 in the same period last year[18] - The total revenue from operating activities reached CNY 718,390,662.18, up 74.5% from CNY 411,406,304.05 in the previous year[19] Assets and Liabilities - The total assets as of September 30, 2022, amounted to ¥2,930,562,844.10, reflecting a significant increase of 344.13% from the end of the previous year[5] - Total assets reached CNY 2,930,562,844.10, compared to CNY 659,845,406.75 at the start of the year, reflecting strong growth[16] - Total liabilities decreased to CNY 156,436,658.19 from CNY 172,573,559.52, indicating improved financial stability[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,191[11] - Major shareholder Yin Hongtao holds 27.92% of shares, totaling 18,987,593 shares[11] - Major shareholder Yin Shiyu holds 24.13% of shares, totaling 16,407,507 shares[11] - The largest unrestricted shareholder, Sun Yixiao, holds 808,084 shares[11] - The company has no known related party relationships among other shareholders[11] - The company has a consistent lock-up period for major shareholders until September 9, 2025[12] Cash Flow - The company’s cash flow from operating activities for the first nine months was ¥108,903,873.81, up 27.70% year-over-year[5] - The net cash flow from operating activities was CNY 108,903,873.81, an increase of 27.7% compared to CNY 85,281,857.08 in the same period last year[19] - The company reported a net cash flow from investment activities of CNY -77,600,435.32, an improvement from CNY -92,770,713.52 in the previous year[20] - The total cash inflow from financing activities was CNY 2,215,188,544.00, a substantial increase from CNY 10,000,000.00 in the same period last year[20] - The net cash flow from financing activities was CNY 2,125,989,435.71, compared to CNY 3,802,464.18 in the previous year[20] Research and Development - Research and development expenses for the first nine months of 2022 were ¥28,672,757.29, an increase of 114.86% compared to the same period in 2021[8] - Research and development expenses increased to CNY 28,672,757.29, up 115.5% from CNY 13,345,151.54 year-on-year, indicating a focus on innovation[17] Equity and Capital - The company’s equity attributable to shareholders increased to ¥2,774,126,185.91, a rise of 469.32% from the previous year-end[5] - The company's equity attributable to shareholders increased significantly to CNY 2,774,126,185.91 from CNY 487,271,847.23, showcasing enhanced shareholder value[16] - The company’s capital reserve increased by 957.00% to ¥2,373,360,838.39, primarily due to the premium from the initial public offering[8] Stock Market Activity - The company received approval from the China Securities Regulatory Commission for its initial public offering on July 20, 2022[13] - The company's ordinary shares were listed on the Shenzhen Stock Exchange on September 9, 2022[13] Inventory and Accounts Receivable - The company reported a significant increase in accounts receivable, which rose by 71.25% to ¥145,821,725.02 due to increased sales and extended credit terms[8] - Inventory as of September 30, 2022, was CNY 71,296,816.52, slightly down from CNY 72,972,684.26 at the beginning of the year[16] Other Information - The company did not report any new product launches or significant market expansion strategies during this quarter[21] - The company reported a net credit impairment loss of CNY -3,154,517.43, compared to a gain of CNY 436,105.33 in the previous year, indicating challenges in credit management[17]
信德新材(301349) - 2022 Q3 - 季度财报